Podcasts about American Journal

Political Establishment Continues Trying To Link Trump, Bannon To Epstein & Alex Jones Joins Transmission On One Year Anniversary Of Democrats Attempting To Shut Down Infowars

What does it actually mean to be "documented" or "undocumented" as a migrant to the USA? What's the lived reality like of existing somewhere in between the two, including under the category of "temporary protected status", or TPS, created by Congress in 1990 for people from countries deemed too unsafe to return to? UCLA sociologist and leading migration expert Cecilia Menjívar joins us to discuss her concept of "liminal legality". Elaborated in a 2006 paper following fieldwork through the 1990s with migrants from Central America, the term remains enduringly relevant in Trump's America - where the administration has moved to roll back TPS for people from countries such as Afghanistan, Venezuela and Syria. A conversation about precarity, lived experience, and policy - and a reminder that "creating a group of people whose rights are diminishing by the day" harms not only those individuals, but all of us.    **Recorded Sept 2025**   Suggested Reading: 'Behind the headlines: Temporary Protected Status', a factsheet from the International Rescue Committee, with links to the latest developments on attempts to end protections for people from Venezuela, Afghanistan, Cameroon, Nepal, Honduras, Nicaragua and Syria '1990: Temporary Protection Status (TPS)' - a research guide from the Library of Congress, A Latinx Resource Guide: Civil Rights Cases and Events in the United States. **including a useful timeline** 'Liminal Legality: Salvadoran and Guatemalan Immigrants' Lives in the United States'  (January 2006) by Cecilia Menjívar in the American Journal of Sociology 'Effects of SB 1070 on Children', by Carlos Santos, Cecilia Menjívar, Erin Godfrey, Pp. 79-92 in Latino Politics and Arizona's Immigration Law SB 1070, edited by Lisa Magaña and Erik Lee. New York: Springer 2013 'Temporary Protected Status for Central American Immigrants: Advancing Immigrant Integration Despite Its Uncertainty' (2020) a policy report by Cecilia Menjívar 'The Ritual Process: Structure and Anti-Structure' (1969) by Victor Turner Update, September 2025: "Judge rules ending protections for Venezuelan and Haitian migrants is unlawful" (BBC News) The work of the National Temporary Protected Status Alliance On the Reagan-backed wars in the 1980s: 'Central America, 1981–1993' from the US Office of the Historian ** An updated TPS factsheet on the status of various designations, from the National Immigration Forum. This includes updates re: Haiti, Venezuela and Syria **   Active listening questions: What did Cecilia mean by "liminal legality" when she coined the term in her 2006 paper? And how is it manifest today?  How might geopolitics play a role in whether an individual with a given nationality is labelled as a refugees or asylum seeker? Why is it important to look beyond labour market experience when we consider the experience of people labelled as migrants? What and what stands to gain when minoritised or vulnerable people are rendered "impermanent" or "temporary"? What does Cecilia's approach show about the value of using sociological research and analysis to complicate seemingly neat binaries?  Cecilia talks about how the precaritisation of some people's migration status "reverberates across US society", impacting us all. What does she mean by this and how does it connect with what Michaela speaks of as "de-migrantising" migration research? 

Newsom's Ex-Chief Of Staff Arrested, Accused Of Stealing $225K! Trump Signs Funding Bill To End Longest Government Shutdown

Well, from time to time we cover RANDOM tidbits of information which cover RANDOM questions and/or RANDOM patient care issues that we encounter. In this episode we will cover one OB issue related to recurrent pregnancy loss, one GYN issue related to unilateral breast swelling in a patient with SLE, and one RANDOM life perspective response from a mock interview that I participated in for a residency candidate. Listen in fordetails!1.     Viviana DO; Giugni, Claudio Schenone MD; Ros, Stephanie T. MD, MSCI. Factor V and recurrent pregnancy loss: de Assis, Evaluation of Recurrent Pregnancy Loss. Obstetrics & Gynecology 143(5):p 645-659, May 2024. | DOI: 10.1097/AOG.0000000000005498Unilateral Breast Swelling with SLE: 2.     Voizard B, Lalonde L, Sanchez LM, et al. LupusMastitis as a First Manifestation of Systemic Disease: About Two Cases With a Review of the Literature. European Journal of Radiology. 2017;92:124-131. doi:10.1016/j.ejrad.2017.04.023.3.     Kinonen C, Gattuso P, Reddy VB. Lupus Mastitis:An Uncommon Complication of Systemic or Discoid Lupus. The American Journal of Surgical Pathology. 2010;34(6):901-6. doi:10.1097/PAS.0b013e3181da00fb.4.      Summers TA, Lehman MB, Barner R, Royer MC. Lupus Mastitis: A Clinicopathologic Review and Addition of a Case. Advances in Anatomic Pathology.2009;16(1):56-61. doi:10.1097/PAP.0b013e3181915ff7.5.     Jiménez-Antón A, Jiménez-Gallo D,Millán-Cayetano JF, Navarro-Navarro I, Linares-Barrios M. Unilateral Lupus Mastitis.Lupus. 2023;32(3):438-440. doi:10.1177/09612033221151011.STRONG COFFEE PROMO: 20% Off Strong Coffee Company https://strongcoffeecompany.com/discount/CHAPANOSPINOBG

House Set To End Schumer Shutdown, UK Stops Sharing Intelligence With US, Massive Solar Flare Could Disrupt Power Grid

Dems Walk Away Empty Handed After Senate Votes To End Longest-Ever Govt Shutdown, Leftist Base  Demands ‘Ruthlessly Pragmatic' Approach to Counter Trump! Newsom Campaigns In Texas, Emerges As Top Dem Pick

Lecture summary: Over centuries and across continents, authoritarian governments have demonstrated a large appetite for international cooperation to target political opponents across borders. As the world's premier body for international police cooperation, Interpol is not supposed to facilitate this kind of transnational repression -- and yet, in recent years, there is growing concern that authoritarian governments are abusing Interpol's tools. Interpol has taken meaningful steps to curb such abuse, but the durability of those protections is in doubt given the rising influence of authoritarian governments in that organization. The looming question is at what point universal multilateral cooperation with respect to law enforcement might cease to be viable.Kristina Daugirdas is the Francis A. Allen Collegiate Professor of Law at the University of Michigan Law School. She teaches and writes primarily in the fields of international law and institutions.Her scholarship currently focuses on international organizations, accountability mechanisms, and the ongoing evolution of the international legal system. She is a member of the editorial board of the International Organizations Law Review and the State Department's Advisory Committee on International Law. She also serves as an adviser to the American Law Institute's Restatement (Fourth) of Foreign Relations Law.In 2016–2017, Daugirdas was a visiting fellow at the Graduate Institute of International and Development Studies in Geneva and served as a consultant on public international law issues for the World Intellectual Property Organization. From 2014 to 2017, she co-authored the Contemporary Practice of the United States Relating to International Law: A section of the American Journal of International Law. In 2014, she was awarded the Francis Deák Prize for an outstanding article published in the American Journal of International Law by a younger author.Daugirdas has taken on significant leadership roles at the law school, including serving as Associate Dean for Academic Programming from 2021 to 2024. She also led a subcommittee of the Advisory Committee on the University of Michigan Principles on Diversity of Thought and Freedom of Expression.Prior to entering academia, Daugirdas was an attorney-adviser at the State Department's Office of the Legal Adviser, receiving multiple honors for her service. As an attorney-adviser, she provided guidance on the negotiation and implementation of UN Security Council sanctions and amicus participation by the US government in lawsuits with foreign policy implications.Chair: Prof Fernando Lusa BordinThis lecture was given on 7 November 2025 and is part of the Friday Lunchtime Lecture series at the Lauterpacht Centre.

Lecture summary: Over centuries and across continents, authoritarian governments have demonstrated a large appetite for international cooperation to target political opponents across borders. As the world's premier body for international police cooperation, Interpol is not supposed to facilitate this kind of transnational repression -- and yet, in recent years, there is growing concern that authoritarian governments are abusing Interpol's tools. Interpol has taken meaningful steps to curb such abuse, but the durability of those protections is in doubt given the rising influence of authoritarian governments in that organization. The looming question is at what point universal multilateral cooperation with respect to law enforcement might cease to be viable.Kristina Daugirdas is the Francis A. Allen Collegiate Professor of Law at the University of Michigan Law School. She teaches and writes primarily in the fields of international law and institutions.Her scholarship currently focuses on international organizations, accountability mechanisms, and the ongoing evolution of the international legal system. She is a member of the editorial board of the International Organizations Law Review and the State Department's Advisory Committee on International Law. She also serves as an adviser to the American Law Institute's Restatement (Fourth) of Foreign Relations Law.In 2016–2017, Daugirdas was a visiting fellow at the Graduate Institute of International and Development Studies in Geneva and served as a consultant on public international law issues for the World Intellectual Property Organization. From 2014 to 2017, she co-authored the Contemporary Practice of the United States Relating to International Law: A section of the American Journal of International Law. In 2014, she was awarded the Francis Deák Prize for an outstanding article published in the American Journal of International Law by a younger author.Daugirdas has taken on significant leadership roles at the law school, including serving as Associate Dean for Academic Programming from 2021 to 2024. She also led a subcommittee of the Advisory Committee on the University of Michigan Principles on Diversity of Thought and Freedom of Expression.Prior to entering academia, Daugirdas was an attorney-adviser at the State Department's Office of the Legal Adviser, receiving multiple honors for her service. As an attorney-adviser, she provided guidance on the negotiation and implementation of UN Security Council sanctions and amicus participation by the US government in lawsuits with foreign policy implications.Chair: Prof Fernando Lusa BordinThis lecture was given on 7 November 2025 and is part of the Friday Lunchtime Lecture series at the Lauterpacht Centre.

Senate Dems Break With Schumer, Advance Plan To End Record-Breaking Gov't Shutdown 

The ACOG acknowledges that maternal obesity affects labor curves and recommends allowing more time for cervical dilation before diagnosing labor arrest in obese patients. This approach aims to avoid unnecessary interventions, such as premature cesarean delivery, which may occur if standard labor curves are strictly applied to obese women. In this episode, we will review a new study from the AJOG (08 Nov 2025) which describes labor progression and duration according to maternal body mass index, validating the need (possibly) for a BMI -based labor curve. Has there been advocates of a BMI-based labor curve? Listen in for details.1. Edwards, Sara et al. Characterizing Labor Progression and Duration According to Maternal Body Mass Index. American Journal of Obstetrics & Gynecology, Volume 0, Issue 02. Lundborg L, Liu X, Åberg K, et al. Association of Body Mass Index and Maternal Age With First Stage Duration of Labour. Scientific Reports. 2021;11(1):13843. doi:10.1038/s41598-021-93217-5.3. Kominiarek MA, Zhang J, Vanveldhuisen P, et al. Contemporary Labor Patterns: The Impact of Maternal Body Mass Index. American Journal of Obstetrics and Gynecology. 2011;205(3):244.e1-8. doi:10.1016/j.ajog.2011.06.014.4. Norman SM, Tuuli MG, Odibo AO, et al. The Effects of Obesity on the First Stage of Labor.Obstetrics and Gynecology. 2012;120(1):130-5. doi:10.1097/AOG.0b013e318259589c.

MOPs & MOEs is powered by TrainHeroic, the best coaching app on the planet. ⁠⁠⁠Click here to get 14 days FREE and a consult with the coaches at TrainHeroic to help you get your coaching business rolling on TrainHeroic. ⁠⁠⁠ MOPs & MOEs delivers our training through ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TrainHeroic and you can ⁠⁠⁠get your first 7 days of training with us FREE by clicking here.⁠⁠⁠To continue the conversation, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠join our Discord!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We have experts standing by to answer your questions.Dr. Rich Willy is a new Associate Professor in the PhD program in the School of Health and Rehabilitation Sciences at The Ohio State University. He holds a PhD in Biomechanics and Movement Science from the University of Delaware and a Master's of Physical Therapy from Ohio University. He is a licensed physical therapist with over two decades of clinical and academic experience. His research focuses on the biomechanics of running-related injuries, bone stress injuries, and rehabilitation strategies for tactical and athletic populations.Dr. Willy has authored more than 80 peer-reviewed publications and book chapters, and his work has been featured in high-impact journals such as British Journal of Sports Medicine, Journal of Orthopaedic & Sports Physical Therapy, and American Journal of Sports Medicine. Dr. Willy contributes to clinical practice guidelines for patellofemoral pain and running injuries. He is a frequently invited speaker at national and international conferences, including symposia for the US and International Olympic Committees, NBA teams, and sports medicine meetings.His research has been supported by the Department of Defense and APTA Orthopaedics, among others. Current projects include optimizing load carriage biomechanics, developing sex-specific training interventions, and advancing wearable technologies for injury prevention and rehabilitation.He and his wife also run Montana Running Lab, a hugely valuable resource curating the best clinical evidence for athletes and rehab professionals. We highly recommend their instagram as an evidence based source of information. We'll talk a bit about some of the resources available there at the end of this episode.

 Bannon Warns MAGA Loyalists Will Be Jailed If GOP Loses Midterms & 2028 Presidential Election, Thousands More Flights Canceled Amid Gov't Shutdown, Muslims Declare New York An Islamic City & Much More

Soms blijft een gebeurtenis maar rondzingen in je hoofd.Je wéét dat het voorbij is, maar je lijf lijkt dat bericht niet te hebben ontvangen. EMDR helpt dan om die herinnering opnieuw te verwerken — zodat de scherpe randjes verdwijnen en het verleden niet telkens aan de deur klopt.Maar wat als je niet eens wéét waar je reactie vandaan komt?Wat als je gedrag al jaren wordt gestuurd door iets wat je je niet kunt herinneren?Daar, in dat onbewuste deel van je brein, werkt hypnose.Niet op het verhaal van wat er gebeurde, maar op de imprint die het heeft achtergelaten.En juist daar zit de sleutel naar rust.EMDR is inmiddels gemeengoed. Hypnose is dat nog niet — al wordt het al in meer dan 70 ziekenhuizen toegepast voor pijn, angst en trauma.Steeds meer artsen zien wat hypnotherapeuten al wisten: mensen zich na hypnotherapie niet alleen beter voelen, maar ook echt vrij.Luister deze aflevering als je nieuwsgierig bent naar wat er gebeurt wanneer het bewuste z'n werk heeft gedaan, maar het onbewuste nog iets te vertellen heeft.Bronnen:– Documentaire Hypnose op Doktersrecept (NPO)– Barabasz et al., American Journal of Clinical Hypnosis, 2014

Russia Closing In On Major Ukrainian City, Putin Mulls Resuming Nuclear Tests As POTUS Pushes For Friday Peace Talks

Mamdani Secures NYC Mayoral Victory, Texas Passes 17 Constitutional Amendments & All US Flights Could Be Grounded By Next Week

Air Traffic Controller Shortage Causes Travel Nightmare Amid Ongoing Schumer Shutdown

Liz Seegert is an award-winning, independent journalist. Liz has written about health for more than 30 years. Her main beats include aging, women's health, social determinants of health, and health policy. Liz's articles have appeared in dozens of national and local media outlets including Scientific American, TIME, The American Journal of Nursing, and Web MD/Medscape. […] The post Narrative Journalism: Stories to Make Points Clear and Compelling (HLOL #265) appeared first on Health Literacy Out Loud Podcast.

Description:  Hosts Roz and Dr. Sanchez-Fueyo are joined by Christie Rampersad to discuss the key articles of the November issue of the American Journal of Transplantation. Christie Rampersad is clinical associate, in the Division of Nephrology at the University of Toronto in the Ajmera Transplant Centre [03:45] The early impacts of an attempt to standardize kidney procurement biopsy practices [13:40] The current state of simultaneous heart-liver transplantation in the United States [20:11] Engaging patients in organ transplant listing meetings: A survey study [37:32] Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells [45:32] Infectious disease surveillance and management in clinical xenotransplantation: Experience with the first human porcine kidney transplant

Trump Calls on Senate to Initiate “Nuclear Option” and Get Rid of Filibuster As SNAP Benefits Set to Run Out! Plus, US Poised to Strike Military Targets In Venezuela

Improving+Healthcare+for+Coptic+Egyptian+MigrantsOpening cultural doors: Providing culturally sensitive healthcare to Arab American and American Muslim patients - American Journal of Obstetrics & GynecologyCultural Competence in the Care of Muslim Patients and Their Families - StatPearls - NCBI Bookshelf No content or comments made in any TIPQC Healthy Mom Healthy Baby Podcast is intended to be comprehensive or medical advice. Neither healthcare providers nor patients should rely on TIPQC's Podcasts in determining the best practices for any particular patient. Additionally, standards and practices in medicine change as new information and data become available and the individual medical professional should consult a variety of sources in making clinical decisions for individual patients. TIPQC undertakes no duty to update or revise any particular Podcast. It is the responsibility of the treating physician or health care professional, relying on independent experience and knowledge of the patient, to determine appropriate treatment.

Trump Resumes US Nuclear Tests After 33-Year Hiatus, Minutes Before Meeting With China's Xi Jinping & Days After Russia Tested High-Tech Nukes

With Sotiria Liori, Attikon University Hospital, National and Kapodistrian University of Athens - Greece and Julie De Backer, Ghent University Hospital - Belgium. In this episode, Sotiria Liori and Julie De Backer discuss heart failure in adult congenital heart disease patients — covering how congenital lesions and prior repairs shape epidemiology and mechanisms (ventricular remodeling, valvular and conduit dysfunction, arrhythmias), as well as clinical assessment with imaging, biomarkers, and hemodynamics. They outline management with guideline-directed therapy, rhythm considerations, indications for advanced therapies (MCS and transplant), and pregnancy counseling. The episode also highlights multidisciplinary care models and key evidence gaps. Proposed reading:  General Principles of Heart Failure Management in Adult Congenital Heart Disease. Tompkins R, Romfh A. Heart Failure Reviews. 2020;25(4):555-567. doi:10.1007/s10741-019-09895-x Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement From the American Heart Association. Stout KK, Broberg CS, Book WM, et al. Circulation. 2016;133(8):770-801. doi:10.1161/CIR.0000000000000352. Relation Between New York Heart Association Functional Class and Objective Measures of Cardiopulmonary Exercise in Adults With Congenital Heart Disease. Das BB, Young ML, Niu J, et al. The American Journal of Cardiology. 2019;123(11):1868-1873. doi:10.1016/j.amjcard.2019.02.053.  Heart Failure and Patient-Reported Outcomes in Adults With Congenital Heart Disease from 15 Countries. Lu CW, Wang JK, Yang HL, Kovacs AH, et al; APPROACH‐IS consortium, the International Society for Adult Congenital Heart Disease (ISACHD) *.J Am Heart Assoc. 2022 May 3;11(9):e024993. doi: 10.1161/JAHA.121.024993. Epub 2022 Apr 26. Pharmacological Therapy in Adult Congenital Heart Disease: Growing Need, Yet Limited Evidence. Brida M, Diller GP, Nashat H, et al. European Heart Journal. 2019;40(13):1049-1056. doi:10.1093/eurheartj/ehy480. Advanced Heart Failure Therapies For Adults With Congenital Heart Disease: JACC State-of-the-Art Review. Givertz MM, DeFilippis EM, Landzberg MJ, et al. Journal of the American College of Cardiology. 2019;74(18):2295-2312.doi:10.1016/j.jacc.2019.09.004. A Review of Heart Transplantation for Adults With Congenital Heart Disease. McMahon A, McNamara J, Griffin M. Journal of Cardiothoracic and Vascular Anesthesia. 2021;35(3):752-762. doi:10.1053/j.jvca.2020.07.027. Heart Failure in Adult Congenital Heart Disease: From Advanced Therapies to End-of-Life Care. Crossland DS, Van De Bruaene A, Silversides CK, Hickey EJ, Roche SL. The Canadian Journal of Cardiology. 2019;35(12):1723-1739. doi:10.1016/j.cjca.2019.07.626. This 2025 HFA Cardio Talk podcast series is supported by Bayer AG in the form of an unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

Food Stamps Run Out In Days, Triggering Massive Unrest Intentionally Unleashed By Democrats' Schumer Shutdown

On this episode of the Hayek Program Podcast, Nina Bandelj delivers a keynote lecture at the 2023 Markets & Society conference on the social life of money for children. Drawing on research about what she calls the “parenting economy,” she shows that parents increasingly treat children as human capital investments, using savings plans, loans, and educational spending to secure their futures. Bandelj argues that the financialization of family life reflects parental pressures and social inequality, calling for children to be seen as a shared public responsibility rather than private investments.Dr. Nina Bandelj is Chancellor's Professor in the Department of Sociology at the University of California, Irvine and the President of the Sociological Research Association. Her articles have been published in top discipline and specialty journals such as the American Sociological Review, American Journal of Sociology, Social Forces, Theory and Society, and Socio-Economic Review. She has published various books, including Overinvested: The Emotional Economy of Modern Parenting (Princeton University Press, forthcoming), Money Talks: Explaining How Money Really Works (Princeton University Press, 2017) coauthored with Frederick Wherry and Viviana Zelizer), and Socialism Vanquished, Socialism Challenged: Eastern Europe and China, 1989-2009 (Oxford university Press, 2012) coedited with Dorothy Solinger.**This lecture was recorded October 22, 2023 at the second annual Markets & Society conference.If you like the show, please subscribe, leave a 5-star review, and tell others about the show! We're available on Apple Podcasts, Spotify, Amazon Music, and wherever you get your podcasts.Check out our other podcast from the Hayek Program! Virtual Sentiments is a podcast in which political theorist Kristen Collins interviews scholars and practitioners grappling with pressing problems in political economy with an eye to the past. Subscribe today!Follow the Hayek Program on Twitter: @HayekProgramFollow the Mercatus Center on Twitter: @mercatusCC Music: Twisterium

Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Sciences Advisory Council, interview Dr. Andrew Lee, Vice President, Clinical Research at Uniquity Bio, about Thymic Stromal Lymphopoietin (TSLP) and eosinophilic esophagitis (EOE). Disclaimer: The information provided in this podcast is designed to support, not replace, the relationship between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:49] Co-host Ryan Piansky introduces the episode, brought to you thanks to the support of Education Partners Bristol Myers Squibb, GSK, Sanofi, Regeneron, and Takeda. Ryan introduces co-host Holly Knotowicz.   [1:13] Holly introduces today's topic, Thymic Stromal Lymphopoietin (TSLP) and eosinophilic esophagitis (EOE), and today's guest, Dr. Andrew Lee, Vice President, Clinical Research at Uniquity Bio.   [1:36] Dr. Lee has nearly 20 years of experience in the clinical development of new vaccines, biologics, and drugs. Holly welcomes Dr. Lee.   [1:52] Dr. Lee trained in internal medicine and infectious diseases.   [1:58] Dr. Lee has been fascinated by the immune system and how it can protect people against infections, what happens when immunity is damaged, as in HIV and AIDS, and how to apply that knowledge to boost immunity with vaccines to prevent infections.   [2:16] Dr. Lee led the clinical development for a pediatric combination vaccine for infants and toddlers. It is approved in the U.S. and the EU.   [2:29] Dr. Lee led the Phase 3 Program for a monoclonal antibody to prevent RSV, a serious infection in infants. That antibody was approved in June 2025 for use in the U.S.   [2:44] In his current company, Dr. Lee leads research into approaches to counteract an overactive immune system. They're looking at anti-inflammatory approaches to diseases like asthma, EoE, and COPD.   [2:58] Dr. Lee directs the ongoing Phase 2 studies that they are running in those areas.   [3:28] Dr. Lee sees drug development as a chance to apply cutting-edge research to benefit people. He trained at Bellevue Hospital in New York City in the 1990s.   [3:40] When Dr. Lee started as an intern, there were dedicated ICU wards for AIDS patients because many of the sickest patients were dying of AIDS and its complications.    [3:52] Before the end of Dr. Lee's residency, they shut down those wards because the patients were on anti-retroviral medications and were doing so well that they were treated as outpatients. They didn't need dedicated ICUs for AIDS patients anymore.   [4:09] For Dr. Lee, that was a powerful example of how pharmaceutical research and drug regimen can impact patients' lives for the better by following the science. That's what drove Dr. Lee to go in the direction of research.   [4:48] Dr. Lee explains Thymic Stromal Lymphopoietin (TSLP). TSLP serves as an alarm signal for Type 2 or TH2 inflammation, a branch of the immune responses responsible for allergic responses and also immunity against parasites.   [5:17] When the cells that line the GI tract and the cells that line the airways in our lungs receive an insult or an injury, they get a danger signal, then they make TSLP.   [5:28] This signal activates other immune cells, like eosinophils and dendritic cells, which make other inflammatory signals or cytokines like IL-4, IL-13, and IL-5.   [5:47] That cascade leads to inflammation, which is designed to protect the body in response to the danger signal, but in some diseases, when there's continued exposure to allergens or irritants, that inflammation goes from being protective to being harmful.   [6:15] That continued inflammation, over the years, can lead to things like the thickened esophagus with EoE, or lungs that are less pliant and less able to expand, in respiratory diseases.   [6:48] Dr. Lee says he thinks of TSLP as being a master switch for this branch of immune responses. If you turn on TSLP, that turns on a lot of steps that lead to generating an allergic type of response.   [7:06] It's also the same type of immune response that can fight off parasite infections. It's the first step in a cascade of other steps generating that type of immune response.   [7:30] Dr. Lee says people have natural genetic variation in the genes that incur TSLP.   [7:38] Observational studies have found that some people with genetic variations that lead to higher levels of TSLP in their bodies had an increased risk for allergic inflammatory diseases like EoE, atopic dermatitis, and asthma.   [8:13] Studies like the one just mentioned point to TSLP being important for increased risk of developing atopic types of diseases like EoE and others. There's been some work done in the laboratory that shows that TSLP is important for activating eosinophils.    [8:38] There's accumulating evidence that TSLP activation leads to eosinophil activation, other immune cells, or white blood cells getting activated.   [9:07] Like a cascade, those cells turn on T-cells and B-cells, which are like vector cells. They lead to direct responses to fight off infections, in case that's the signal that leads to the turning on TSLP.   [9:48] Ryan refers to a paper published in the American Journal of Gastroenterology exploring the role of TSLP in an experimental mouse model of eosinophilic esophagitis. Ryan asks what the researchers were aiming to find.   [10:00] Dr. Lee says the researchers were looking at the genetic studies we talked about, the observational studies that are beginning to link more TSLP with more risk for EoE and those types of diseases.   [10:12] The other type of evidence that's accumulating is from in vitro (in glass) experiments or test tube experiments, where you take a couple of cells that you think are relevant to what's going on.   [10:28] For example, you could get some esophageal cells and a couple of immune cells, and put TSLP into the mix, and you see that TSLP leads to activation of those immune cells and that leads to some effects on the esophageal cells.   [10:42] Those are nice studies, but they're very simplified compared to what you can do in the body. These researchers were interested in extending those initial observations from other studies, but working in the more realistic situation of a mouse model.   [11:00] You have the whole body of the mouse being involved. You can explore what TSLP is doing and model a disease that closely mimics what's happening with EoE in humans.   [12:23] They recreated the situation of what seems to be happening in EoE in people. We haven't identified it specifically, but there's some sort of food allergen in patients with EoE that the immune system is set off by.   [12:55] What researchers are observing in this paper is that in these mice that were treated with oxazolone, there is inflammation in the esophagus, an increase in TSLP levels, and eosinophils going into the esophageal tissues.   [13:15] Dr. Lee says, that's one of the main ways we diagnose EoE; we take a biopsy of the esophagus and count how many eosinophils there are. Researchers saw similar findings. The eosinophil count in the esophageal tissues went way up in these mice.    [13:34] Researchers also saw other findings in these mice that are very similar to EoE in humans, such as the esophageal cells lining the esophagus proliferating. They even saw that new blood vessels were being created in that tissue that's getting inflamed.   [14:00] Dr. Lee thinks it's a very nice paper because it shows that correlation: Increase TSLP and you see these eosinophils going to the esophagus, and these changes that are very reminiscent of what we see in people with EoE.   [14:51] In this paper, the mice made the TSLP, and researchers were able to measure the TSLP in the esophageal tissue. The researchers didn't introduce TSLP into the mice. The mice made the TSLP in response to being repeatedly exposed to oxazolone.   [15:20] That's key to the importance of the laboratory work. The fact that the TSLP is made by the mice is important. It makes it a very realistic model for what we're seeing in people.   [15:41] In science, we like to see correlation. The researchers showed a nice correlation.   [15:46] When TSLP went up in these mice, and the mice were making more TSLP on their own, at the same time, they saw all these changes in the esophagus that look a lot like what EoE looks like in people.    [16:01] They saw the eosinophils coming into the esophagus. They saw the inflammation go up in the esophagus. What Dr. Lee liked about this paper is that they continued the story.   [16:15] The researchers took something that decreases TSLP levels, an antibody that binds to and blocks TSLP, and when they did that, they saw the TSLP levels come down to half the peak level.   [16:35] Then they saw improvement in the inflammation in the esophagus. They saw that the amount of eosinophils decreased, and the multiplication of the esophageal cells went down. The number of new blood vessels went down after the TSLP was reduced.   [16:53] Dr. Lee says, you see correlation. The second part is evidence for causation. When you take TSLP away, things get better. That gives us a lot of confidence that this is a real finding. It's not just observational. There is causation evidence here.   [18:26] Ryan asks if cutting TSLP also help reduce other immune response cells. Dr. Lee says TSLP is the master regulator for this Type 2 inflammation. It definitely touches and influences other cells besides eosinophils.   [18:44] TSLP affects dendritic cells, which are an important type of immune cell, like a coordinating cell that instructs other cells within the immune system what to do. In this paper, they looked at a lot of other effects of TSLP on the tissues of the body.   [19:10] Dr. Lee says, There's a lot of research on TSLP, and one of the reasons we're excited about the promise of TSLP is that it's so far upstream; so much of the beginning, that it's affecting other cells.   [19:29] Its effects could be quite broad. If we're able to successfully block TSLP, we could block a lot of different effects.   [19:40] One treatment for EoE is dupilumab, which blocks IL-4 and IL-13 specifically, and that works well, but TSLP has the potential to have an even greater effect than blocking IL-4 and IL-13, since it is one step before turning on IL-4 and IL-13.    [20:14] That's one of the reasons researchers are excited about the promise of blocking TSLP. There are studies ongoing of TSLP blockers in people with EoE.   [20:34] Ryan asks if there are negative repercussions from blocking TSLP. Dr. Lee says in this study and in people, we are not completely blocking TSLP by any means. There will still be residual TSLP activated, even with very potent drugs.   [21:01] In the study, they block TSLP about 50%‒60%. TSLP is involved in immunity against parasites. In studies with people, they make sure not to include anybody who has an active parasitic infection. A person under treatment should not be in a study.   [21:27] Dr. Lee says we haven't seen any problems with parasitic infections becoming more severe, but that is a theoretical possibility, so for that reason, in studies with TSLP blockers, we generally exclude patients with known parasitic infections.   [22:17] What excited Dr. Lee in this paper was that they showed that when you block TSLP in the mice, then you get real effects in their tissues. Eosinophils went away. The thickening of the basal layers in the esophagus got much better.   [22:38] That kind of real effect reflected in the tissue is super exciting to see. That gives us more confidence that this could work in people, since we're seeing it in a realistic whole-body model in the mice.   [23:12] Dr. Lee says there are ongoing clinical studies on TSLP blockers for EoE. His company is studying an antibody that blocks TSLP in eczema, COPD, and EoE. One of the exciting things about immunology is that it affects many different parts of the body.   [23:42] EoE is associated with other immune-type disorders. There's a high percentage of patients with EoE who have other diseases. EoE coexists with asthma, atopic dermatitis, and chronic rhinitis.   [24:09] It's exciting that if you figure out something that's promising for one disease that TSLP affects, it could have very broad-ranging implications for a variety of diseases.   [24:22] Ryan shares his experience of his doctor talking to him about a TSLP blocker, tezepelumab, as a potential option when it's out of clinical trials. It would target something a little higher up the chain and help with some of his remaining symptoms.   [24:59] Ryan is excited to hear that this research is so encouraging and how it could potentially help treat EoE, asthma, and other conditions, all at once.   [25:16] Dr. Lee says that being in these later-stage studies is super exciting. If these late-stage trials are successful, the next step is to apply for regulatory approval with the various agencies around the world.   [26:40] Dr. Lee shares one takeaway for listeners to remember. Think of TSLP as an alarm that turns on inflammation. He compares TSLP to turning on an alarm during a robbery. There are multiple steps designed to protect the bank and the money.   [27:20] To extend that analogy, with TSLP, once you turn it on, all these other steps are going to happen. Inflammation is designed to protect the body. It's a protective response. If there's an infection, it can clear the infection.   [27:38] If the infection persists, as in HIV, the immune response, which is protective and beneficial, eventually becomes damaging. It becomes dysfunctional. In EoE, if you continually eat the allergic food, the inflammation becomes damaging to the esophagus.   [28:27] Long-term inflammation leads to replacing the normal esophageal tissue with fibrotic tissue, and that's why the esophagus eventually gets hardened and less able to let the food go through.   [28:40] In respiratory diseases, the soft tissue of the lung gets replaced with thicker tissue, and the lung is not able to expand.   [28:54] Dr. Lee says he people to think about TSLP as this master alarm switch. We hope that if you could turn off that TSLP, you could then avoid a lot of the complications that we see with chronic inflammation in these conditions.   [29:14] We're hopeful that you could even take away the symptoms that you see in these diseases, make patients feel better, and with extended treatment, you could begin to reverse some of the damage resulting from inflammation.   [29:32] Ryan likes that analogy and how Dr. Lee has concisely explained these complicated concepts.   [29:51] Dr. Lee thanks Holly and Ryan and adds one more plea to listeners. Please consider getting involved with research. Clinical trials cannot be done without patients. We need patients to advance new treatments.   [30:27] Researchers like Dr. Lee spend a lot of time thinking about how to make the studies not only informative but also fair to patients who decide to become involved. It's a lot of work and a fair amount of time commitment.   [30:44] If you don't want to be in a study, you can help by being on a patient feedback panel and reviewing protocols and informed consents. Follow your interests. Think about getting involved with research, however you can.   [31:06] Ryan and Holly are very grateful for the community, with so many wonderful clinicians and researchers, and so many patients who are willing to volunteer their time and their data to help researchers find better solutions going forward.   [31:26] Ryan thanks Dr. Lee for coming on and putting out that call to action. It's a great reminder for listeners and the patients in the community to look for those opportunities. Chat with your physician. Go to APFED's website. There's a link to active clinical trials.   [31:47] For our listeners who want to learn more about eosinophilic disorders, we encourage you to visit apfed.org and check out the links in the show notes below.   [31:53] For those looking to find specialists who treat eosinophilic disorders, we encourage you to use APFED's Specialist Finder at apfed.org/specialist.   [32:01] If you'd like to connect with others impacted by eosinophilic diseases, please join APFED's online community on the Inspire Network at apfed.org/connections.   [32:11] Ryan thanks Dr. Andrew Lee for joining us today. We learned a lot. Holly also thanks APFED's Education Partners Bristol Myers Squibb, GSK, Sanofi, Regeneron, and Takeda for supporting this episode.   Mentioned in This Episode: Andrew Lee, M.D., VP Clinical Research, Uniquity Bio   "A Mouse Model for Eosinophilic Esophagitis (EoE)" Current Protocols, Wiley Online Library   APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast apfed.org/specialist apfed.org/connections apfed.org/research/clinical-trials   Education Partners: This episode of APFED's podcast is brought to you thanks to the support of Bristol Myers Squibb, GSK, Sanofi, Regeneron, and Takeda.   Tweetables:   "I see drug development as a chance to apply cutting-edge research to benefit people." — Andrew Lee, M.D.   "When the cells that line the GI tract and the cells that line the airways in our lungs receive an insult or an injury, they get a danger signal, then they make TSLP." — Andrew Lee, M.D.   "Observational studies have found that some people with genetic variations that lead to higher levels of TSLP in their bodies had an increased risk for allergic inflammatory diseases like EoE, atopic dermatitis, and asthma." — Andrew Lee, M.D.   "There's a lot of research on TSLP, and one of the reasons we're excited about the promise of TSLP is that it's so far upstream; so much of the beginning, that it's affecting other cells." — Andrew Lee, M.D.   "Please consider getting involved with research. We can't do these clinical trials without patients. We need patients to advance new treatments for patients." — Andrew Lee, M.D.

Venezuela Says It Captured CIA Group Planning False Flag Attack, Maduro Condemns US “Military Provocation” As White House Considers Air Force Strikes

In this episode of the Glowing Older podcast, host Nancy Griffin interviews Dr. Kenneth Pelletier, a clinical professor of medicine and psychiatry at UCSF, about the science of longevity and the role of epigenetics. Dr. Pelletier shares insights into the importance of healthspan over lifespan, and the impact of diet, stress, exercise, and social support on longevity. He also discusses the potential and limitations of biohacking and the growing field of integrative medicine. About Dr. Pelletier Kenneth R. Pelletier, PhD, MD is a Clinical Professor of Medicine, Department of Medicine; Department of Family and Community Medicine; and Department of Psychiatry at the University of California School of Medicine (UCSF) in San Francisco; and a Clinical Professor of Medicine in the Department of Medicine and Department Family and Community Medicine at the University of Arizona School of Medicine in Tucson. At the present time, Dr. Pelletier is a medical and business consultant to the US Department of Health and Human Services, the World Health Organization (WHO), the National Business Group on Health, the Federation of State Medical Boards, the Wild Dolphin Project, and major corporations including Cisco, IBM, American Airlines, Prudential, Dow, Disney, Ford, Mercer, Merck, Pepsico, Ford, Pfizer, Walgreens, NASA, Microsoft ENCARTA, Blue Cross/Blue Shield, United Healthcare, Health Net, the Pasteur Institute of Lille, France, the Alpha Group of Mexico, and the Singapore Ministry of Health. He also serves on the boards of the Rancho la Puerta (Mexico), Nova Institute, Fries Foundation, American Institute of Stress (AIS), American Journal of Health Promotion (AJHP), as a Founding Board Member of the American Board of Integrative Medicine (ABOIM), and as a peer reviewer for the Journal of the American Medical Association (JAMA), the Journal of Occupational and Environmental Medicine (JOEM), Annals of Internal Medicine, Health Affairs, and webMD.  Dr. Pelletier is listed in Who's Who in America and in Who's Who in the World. He has been featured on ABC World News, the Today program, Good Morning America, Dr Oz, the CBS Evening News, 48 Hours, the McNeil-Lehrer Newshour, CNN, FOX News, and CBS Sunday Morning.Dr. Pelletier is the author of 15 major books including the international bestseller Mind as Healer, Mind as Slayer; Holistic Medicine: From Stress to Optimum Health; Longevity: Fulfilling Our Biological Potential; Healthy People in Unhealthy Places; Stress and Fitness at Work; Sound Mind – Sound Body: A New Model for Lifelong Health; The Best Alternative Medicine: What Works? What Does Not?; Stress Free for Good: Ten Scientifically Proven Life Skills for Health and Happiness; New Medicine: How to Integrate Conventional and Alternative Medicine for the Safest and Most Effective Treatment and Change Your Genes – Change Your Life: Creating Optimal Health with the New Science ofEpigenetics.Key TakeawaysEpigenetics is a relatively new science, developed in the last 15 years. Epigenetics are all of the influences that determine our health, wellbeing, and life expectancy after the sperm and ovum unite. Epigenetics plays a crucial role in determining health and life expectancy – 95 % of health, illness, and life expectancy are due to factors other than our genes. The role of diet, stress, physical activity and social support significantly influence genetic expression.There are no longitudinal studies for biohacking. Don'tgo into the periphery and engage in questionable practices. Sort hope from hype.Equal criteria for evaluating the outcomes of alternative and conventional medicine must be applied; both should be held to the same rigorous scientific standards to ensure their acceptability and effectiveness.

A reading of articles and features from the October/November 2025 Issue of the Polish American Journal

Russia Tests High-Tech Nukes While Trump Asks Xi For Help Ending Ukraine War & USA Prepares To Strike Venezuela

This week on The Sausage of Science, Chris and Cara talk with Dr. Josh Brahinsky, a researcher in the Transcultural Psychiatry Department at McGill University and the Department of Religious Studies at Stanford University, whose work sits at the intersection of anthropology, psychology, and neuroscience. Josh explores how contemplative practices like prayer and meditation shape sensory experience, perception, and emotion, focusing especially on the embodied and affective dimensions of charismatic evangelical worship. With a background that bridges the humanities and sciences, a PhD in the History of Consciousness from UCSC, and a postdoctoral fellowship in Anthropology at Stanford, Josh brings a truly interdisciplinary lens to understanding what happens when people reach for the divine, and how those moments transform the body and mind alike. ------------------------------ Find the book discussed in this episode: Tongues of Fire: How Charismatic Prayer Changes Evangelical Brains and Mobilizes Spirit-Filled Activism www.bloomsbury.com/us/tongues-of-f…-9798881804992/ Find the Article: Brahinsky, J., Mago, J., Miller, M., Catherine, S., & Lifshitz, M. (2024). The Spiral of Attention, Arousal, and Release: A Comparative Phenomenology of Jhāna Meditation and Speaking in Tongues. American Journal of Human Biology, 36(12), e24189. doi.org/10.1002/ajhb.24189 ------------------------------ Contact Dr. Brahinsky: jbrahins@gmail.com ------------------------------ Contact the Sausage of Science Podcast and Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Cara Ocobock, Host Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu, Twitter:@CaraOcobock Cristina Gildee, SoS Co-Producer, HBA Fellow Website: cristinagildee.org, E-mail: cgildee@uw.edu,

Chocolate, cheese, and wine — the holy trinity of migraine “triggers.” But what if they're not villains, after all, but messengers from your body asking you to listen more closely?In this episode of Migraine Heroes Podcast, host Diane Ducarme explores the real story behind these indulgences — and why your reactions to them may reveal more about your brain and gut health than about the foods themselves.We blend neuroscience, gut microbiome research, and Eastern medicine wisdom to uncover how pleasure and balance coexist — even in the migraine world.You'll discover:

Bondi Tells Pelosi to “Preserve Her Emails” After She Called For ICE Agents To Be Arrested

Gov't Shutdown Enters Day 23 As Democrats Attempt To Implode Trump Economy, Launch Domestic Uprising & Blame MAGA For It All

Dr. Ryan Sultan is a Board Certified Adult and Child Psychiatrist, researcher and Assistant Professor of Clinical Psychiatry at Columbia University Irving Medical Center. He is also in private practice with expertise in the evaluation and treatment of ADHD. One in six American boys is now diagnosed with ADHD. In France, it's one in 200. American children are diagnosed with ADHD at rates 30 times higher than other Western nations. We consume 80% of the world's ADHD stimulants despite being 4% of the population.There's no blood test, no brain scan, no biological evidence this "disorder" actually exists - just subjective checklists and lines of questioning. In this essential episode, Dr. McFillin challenges the validity and reliability of ADHD diagnosis, and what unfolds is a stunning revelation about how 7 million children ended up on amphetamines. References:MTA Study (Multimodal Treatment Study of ADHD):MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for ADHD. Archives of General Psychiatry, 56(12), 1073-1086.Molina, B. S., et al. (2009). MTA at 8 years: Prospective follow-up of children treated for combined-type ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 48(5), 484-500.Key finding: No difference in outcomes between medicated and non-medicated groups at 3-year and 8-year follow-upsCDC ADHD Statistics:CDC. (2022). Data and Statistics About ADHD. Centers for Disease Control and Prevention.7.1 million US children diagnosed with ADHD (11.4% of all children)15.5% of boys diagnosed vs. 7.5% of girls1 in 6 boys aged 4-17 diagnosed with ADHD3.3 million children aged 3-17 currently on ADHD medicationRacial Disparities in Diagnosis of ADHDDSM-5 Field Trial Reliability:Regier, D. A., et al. (2013). DSM-5 field trials in the United States and Canada. American Journal of Psychiatry, 170(1), 59-70.ADHD kappa reliability: 0.61 (research settings) to 0.35 (clinical practice)Financial Data:ADHD medication market: $19.8 billion (2024, Market Research Reports)10-fold increase in stimulant prescriptions: 1990-2024 (DEA production quotas) Faraone, S.V., Sergeant, J., Gillberg, C., & Biederman, J. (2003). The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry, 2(2), 104-113.Funded by Johnson & Johnson (pharmaceutical company)Co-authored by Joseph Biederman (who later had to admit taking $1.6 million from drug companies without disclosure)What This Article Inadvertently Reveals:The Diagnosis Shopping Game: The article admits that using DSM-IV criteria produces the "highest prevalence rates" compared to other diagnostic systems. Translation: American psychiatry created diagnostic criteria that captures the most kids. This isn't discovering disease - it's widening the net.The 20-Fold Difference They Can't Explain: The article acknowledges a "20-fold greater prevalence of childhood hyperactivity in North America compared with England" in 1970s studies. Their explanation? Different diagnostic practices, not different children. So they're admitting the "disease" depends entirely on who's doing the diagnosing.The Admission Hidden in Plain Sight: The authors state that differences in prevalence "reflect differences in diagnostic practice rather than true differences in behavior." They're literally admitting ADHD prevalence is about diagnostic opinion, not biological reality.Even establishment researchers like Faraone admit that ADHD prevalence varies 20-fold based on diagnostic criteria used, not actual differences in children's behavior. They acknowledge it's diagnostic practice, not disease prevalence, that creates these massive variations. This 2003 paper proves psychiatry has known for decades that ADHD rates are artificially inflated by American diagnostic criteria.The Irony: This paper, trying to prove ADHD is universal, actually proves it's a diagnostic construct that changes based on which manual you use. That's not how real diseases work. Visit Center for Integrated Behavioral HealthDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

Feds Face Off With Antifa Outside Portland ICE Facility As Local Police Continue Protecting Commies Instead Of Federal Agents

Democrat Chicago Judge Rules ICE Agents Can Be Arrested For Apprehending Illegals

On this episode of Managed Care Cast, The American Journal of Managed Care® speaks with Melanie T. Turk, PhD, RN, an associate professor in the School of Nursing at Duquesne University and author of a study published in the October 2025 issue. Despite its potential, her study, "Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program," examines the challenges of implementing the Medicare Diabetes Prevention Program (MDPP) from the perspective of program suppliers nationwide. In this conversation, Turk discusses the limited adoption of the MDPP and the inspiration behind her study. She also outlines her key findings and shares next steps for implementing and sustaining the program.

A study published in the American Journal of Clinical Nutrition showed that eating two eggs daily lowered LDL cholesterol, while high saturated fat diets raised it Researchers found cholesterol from eggs did not raise LDL, but saturated fat from foods like bacon and sausage did, showing food context makes a major difference Eggs provide cholesterol without overloading the liver, allowing it to clear LDL efficiently and preventing artery buildup that increases heart disease and stroke risk Weekly egg intake reduced heart disease deaths by 29% and all-cause mortality by 17% in older adults, highlighting the importance of moderation for protective benefits Choosing pastured eggs, avoiding vegetable oils, and pairing eggs with nutrient-rich whole foods further boost benefits while minimizing harmful omega-6 linoleic acid (LA) intake

Trump Warns Zelensky To Accept Russia's Terms Or Be Destroyed Ahead Of Budapest Peace Summit Meeting With Putin

 US Special Ops & B-52s Train Near Venezuela, Trump Threatens American Military Action In Gaza As Dems Activate Leftist Mob For Civil Unrest

This week on The Sausage of Science, Chris and Cara talk with Dr. Josh Brahinsky, a researcher in the Transcultural Psychiatry Department at McGill University and the Department of Religious Studies at Stanford University, whose work sits at the intersection of anthropology, psychology, and neuroscience. Josh explores how contemplative practices like prayer and meditation shape sensory experience, perception, and emotion, focusing especially on the embodied and affective dimensions of charismatic evangelical worship. With a background that bridges the humanities and sciences, a PhD in the History of Consciousness from UCSC, and a postdoctoral fellowship in Anthropology at Stanford, Josh brings a truly interdisciplinary lens to understanding what happens when people reach for the divine, and how those moments transform the body and mind alike. ------------------------------ Find the book discussed in this episode: Tongues of Fire: How Charismatic Prayer Changes Evangelical Brains and Mobilizes Spirit-Filled Activism https://www.bloomsbury.com/us/tongues-of-fire-9798881804992/ Find the Article: Brahinsky, J., Mago, J., Miller, M., Catherine, S., & Lifshitz, M. (2024). The Spiral of Attention, Arousal, and Release: A Comparative Phenomenology of Jhāna Meditation and Speaking in Tongues. American Journal of Human Biology, 36(12), e24189. https://doi.org/10.1002/ajhb.24189 ------------------------------ Contact Dr. Brahinsky: jbrahins@gmail.com ------------------------------ Contact the Sausage of Science Podcast and Human Biology Association: Facebook: facebook.com/groups/humanbiologyassociation/, Website: humbio.org, Twitter: @HumBioAssoc Chris Lynn, Host Website: cdlynn.people.ua.edu/, E-mail: cdlynn@ua.edu, Twitter:@Chris_Ly Cara Ocobock, Host Website: sites.nd.edu/cara-ocobock/, Email:cocobock@nd.edu, Twitter:@CaraOcobock Cristina Gildee, SoS Co-Producer, HBA Fellow Website: cristinagildee.org, E-mail: cgildee@uw.edu,

Trump Reportedly Approves CIA Regime Change In Venezuela, Mulls Lethal Strikes

Los Angeles Declares State Of Emergency & Chicagoans Fight ICE In The Streets As Democrat ‘Podesta Plan' Of Civil Unrest Kicks Into High Gear

Internationally renouned kidney stone dietitian & researcher. Dr. Kristina Penniston PhD RDN, dives into updates in research for kidney stones, what diets are best for kidney stones and an updated approach to managing oxalate. Bio: Dr. Kristina Penniston References: Noori N,  et al. Urinary Lithogenic Risk Profile in Recurrent Stone Formers With Hyperoxaluria: A Randomized Controlled Trial Comparing DASH (Dietary Approaches to Stop Hypertension)-Style and Low-Oxalate Diets. American Journal of Kidney Diseases. 2014;63(3):456-463.  Rodriguez A, et al. Mediterranean diet adherence and risk of incident kidney stones. The American Journal of Clinical Nutrition. 2020;111(5):1100-1106. Oxalate Blog Posts: Is a Low Oxalate Diet Necessary? How a Low Oxalate Diet Could Make Kidney Stones Worse   Submit a question for Melanie to answer on the podcast! Connect with The Kidney Dietitian! Work with Us! |  Instagram | Facebook | Pinterest | Facebook Group | Newsletter www.thekidneydietitian.org FREE Webinar: The 3-Step Method to Prevent Kidney Stones All information in this podcast is meant for educational purposes only and should not be used in place of advice from a medical professional.  

Senate To Vote On Gov't Spending Bill, Portland Antifa Insurrectionists Receive U-Haul Full Of Supplies, Schumer Promotes Anti-Trump Uprising

WWIII Alert! Russia Hints At NUCLEAR Response If Trump Supplies Ukraine With U.S. Tomahawk Missiles

 Soros Operative Letitia James Indicted, Deep State In Full Panic Mode As They Need Minions To Believe They're Above The Law! Plus, Gaza Ceasefire Now In Effect

1984! Zelensky Says Ukraine Will Nominate Trump For Nobel Peace Prize If He Sends Tomahawk Missiles

These diseases - West Nile Virus, Lyme disease, and Rocky Mountain Spotted Fever - are named for the places where outbreaks happened. But they're also all things you get from being bitten by mosquitoes or ticks. Research: Balasubramanian, Chandana. “Rocky Mountain Spotted Fever (RMSF): The Deadly Tick-borne Disease That Inspired a Hit Movie.” Gideon. 9/1/2022. https://www.gideononline.com/blogs/rocky-mountain-spotted-fever/ Barbour AG, Benach JL2019.Discovery of the Lyme Disease Agent. mBio10:10.1128/mbio.02166-19.https://doi.org/10.1128/mbio.02166-19 Bay Area Lyme Foundation. “History of Lyme Disease.” https://www.bayarealyme.org/about-lyme/history-lyme-disease/ Caccone, Adalgisa. “Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes.” Yale School of Medicine. 8/28/2017. https://medicine.yale.edu/news-article/ancient-history-of-lyme-disease-in-north-america-revealed-with-bacterial-genomes/ Chowning, William M. “Studies in Pyroplasmosis Hominis.("Spotted Fever" or "Tick Fever" of the Rocky Mountains.).” The Journal of Infectious Diseases. 1/2/1904. https://archive.org/details/jstor-30071629/page/n29/mode/1up Elbaum-Garfinkle, Shana. “Close to home: a history of Yale and Lyme disease.” The Yale journal of biology and medicine vol. 84,2 (2011): 103-8. Farris, Debbie. “Lyme disease older than human race.” Oregon State University. 5/29/2014. https://science.oregonstate.edu/IMPACT/2014/05/lyme-disease-older-than-human-race Galef, Julia. “Iceman Was a Medical Mess.” Science. 2/29/2012. https://www.science.org/content/article/iceman-was-medical-mess Gould, Carolyn V. “Combating West Nile Virus Disease — Time to Revisit Vaccination.” New England Journal of Medicine. Vol. 388, No. 18. 4/29/2023. https://www.nejm.org/doi/full/10.1056/NEJMp2301816 Harmon, Jim. “Harmon’s Histories: Montana’s Early Tick Fever Research Drew Protests, Violence.” Missoula Current. 7/20/2020. https://missoulacurrent.com/ticks/ Hayes, Curtis G. “West Nile Virus: Uganda, 1937, to New York City, 1999.” From West Nile Virus: Detection, Surveillance, and Control. New York : New York Academy of Sciences. 2001. https://archive.org/details/westnilevirusdet0951unse/ Jannotta, Sepp. “Robert Cooley.” Montana State University. 10/12/2012. https://www.montana.edu/news/mountainsandminds/article.html?id=11471 Johnston, B L, and J M Conly. “West Nile virus - where did it come from and where might it go?.” The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 11,4 (2000): 175-8. doi:10.1155/2000/856598 Lloyd, Douglas S. “Circular Letter #12 -32.” 8/3/1976. https://portal.ct.gov/-/media/departments-and-agencies/dph/dph/infectious_diseases/lyme/1976circularletterpdf.pdf Mahajan, Vikram K. “Lyme Disease: An Overview.” Indian dermatology online journal vol. 14,5 594-604. 23 Feb. 2023, doi:10.4103/idoj.idoj_418_22 MedLine Plus. “West Nile virus infection.” https://medlineplus.gov/ency/article/007186.htm National Institute of Allergy and Infectious Disease. “History of Rocky Mountain Labs (RML).” 8/16/2023. https://www.niaid.nih.gov/about/rocky-mountain-history National Institute of Allergy and Infectious Disease. “Rocky Mountain Spotted Fever.” https://www.niaid.nih.gov/diseases-conditions/rocky-mountain-spotted-fever Rensberger, Boyce. “A New Type of Arthritis Found in Lyme.” New York Times. 7/18/1976. https://www.nytimes.com/1976/07/18/archives/a-new-type-of-arthritis-found-in-lyme-new-form-of-arthritis-is.html?login=smartlock&auth=login-smartlock Rucker, William Colby. “Rocky Mountain Spotted Fever.” Washington: Government Printing Office. 1912. https://archive.org/details/101688739.nlm.nih.gov/page/ Sejvar, James J. “West Nile virus: an historical overview.” Ochsner journal vol. 5,3 (2003): 6-10. https://pmc.ncbi.nlm.nih.gov/articles/PMC3111838/ Smithburn, K.C. et al. “A Neurotropic Virus Isolated from the Blood of a Native of Uganda.” The American Journal of Tropical Medicine and Hygiene. Volume s1-20: Issue 4. 1940. Steere, Allen C et al. “The emergence of Lyme disease.” The Journal of clinical investigation vol. 113,8 (2004): 1093-101. doi:10.1172/JCI21681 Steere, Allen C. et al. “Historical Perspectives.” Zbl. Bakt. Hyg. A 263, 3-6 (1986 ). https://pdf.sciencedirectassets.com/281837/1-s2.0-S0176672486X80912/1-s2.0-S0176672486800931/main.pdf World Health Organization. “West Nile Virus.” 10/3/2017. https://www.who.int/news-room/fact-sheets/detail/west-nile-virus Xiao, Y., Beare, P.A., Best, S.M. et al. Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine. Sci Rep 13, 4687 (2023). https://doi.org/10.1038/s41598-023-31894-0 See omnystudio.com/listener for privacy information.